This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Geistlich Pharma Ag. Active years: 2019-2026.
Company Filing History:
Years Active: 2019-2026
Title: Innovations by Raphael Kaufmann
Introduction
Raphael Kaufmann is a notable inventor based in Ballwil, Switzerland. He has made significant contributions to the field of medical technology, particularly in the development of resorbable membranes for tissue regeneration. With a total of 3 patents, his work is recognized for its innovative approach to enhancing surgical outcomes.
Latest Patents
Kaufmann's latest patents include a "Resorbable crosslinked form stable membrane for use outside the oral cavity." This invention relates to a composite layer of collagen material and inorganic ceramic particles, designed for human tissue regeneration in procedures such as rhinoplasty and spinal fusion. The membrane comprises a specific ratio of inorganic ceramic to collagen material, ensuring its effectiveness in medical applications. Another patent, titled "Resorbable crosslinked form stable membrane," shares similar characteristics, emphasizing the importance of collagen and elastin in its composition.
Career Highlights
Raphael Kaufmann is associated with Geistlich Pharma AG, a company known for its advancements in regenerative medicine. His work at Geistlich Pharma AG has positioned him as a key player in the development of innovative medical solutions. His contributions have not only advanced the field but have also improved patient care in various surgical procedures.
Collaborations
Kaufmann has collaborated with esteemed colleagues such as Niklaus Stiefel and Sergej Stenzel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical technology.
Conclusion
Raphael Kaufmann's contributions to the field of medical technology through his patents and collaborations highlight his commitment to advancing surgical techniques and improving patient outcomes. His work continues to inspire innovation in tissue regeneration.